Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Mileutis
Mileutis Overview
Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe, and residual-free therapies for animal and human health.
Mileutis has developed a line of biopharmaceuticals that are revolutionizing the way in which farmers and veterinarians treat a wide range of diseases. Mileutis’ first products are comprised of peptides and specific protein fragments that have a positive impact on body functions and conditions that influence health. These peptides act through an immune-modulatory effect, enabling the management of infectious and chronic diseases without the use of antibiotics, thereby reducing the use of antibiotics in animal and human healthcare. This will assist in overcoming the global threat of antimicrobial resistance (AMR) generated by, among other things, the overuse of antibiotics.
The company's lead products are Imilac and Milac, which target the management, treatment, and prevention of mastitis in dairy cows. Mileutis's products aim to replace antibiotics in dairy farms, improve cow wellbeing, and provide additional and significant economic value to farmers by increasing milk yield and productivity.
Mileutis' Imilac™ product shown as a successful antibiotic alternative in the management of the leading problem of the dairy industry: Mastitis
Leading journal of dairy sciences recently publishes a study that presents a case for antibiotic alternatives to treat cows at dry-off
#Customers
Jan 11, 2021
www.dairybusiness.com
Mileutis to Present at the 39th Annual J.P. Morgan Healthcare Conference
Mileutis' Imilac™ product shown as a successful antibiotic alternative in the management of the leading problem of the dairy industry: Mastitis
Leading journal of dairy sciences recently publishes a study that presents a case for antibiotic alternatives to treat cows at dry-off
#Customers
Jan 11, 2021
www.dairybusiness.com
Mileutis to Present at the 39th Annual J.P. Morgan Healthcare Conference
undefined
View other companies you might be interested in
Mileutis Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.